Laboratory Sector Today 20: Can Boring Laboratory Businesses Beat the Market?

1. Status

Proposed. Constituents are not final: no list of 20 has been selected, and none will be until the rules below are applied to licensed reference data. Example names below are verified listings that meet the industry definition. They are not selections.

2. Eligibility (proposed)

• Primary listing on a regulated exchange, with the ticker and exchange verified against company investor-relations pages.
• Majority of revenue from laboratory testing, laboratory instruments/consumables, diagnostics or laboratory software and services, based on the latest annual filing segment disclosure.
• Private companies (for example Pace, Element, NSF, Microbac) are excluded because they have no public shares.

3. Hypothetical weighting

Two options are under consideration and would be shown side by side: equal weight (5% each at rebalance), which avoids domination by the largest companies, and capped free-float market-cap weight (for example a 10% single-name cap), which reflects investable size. Both are illustrative calculations, never holdings.

4. Rebalancing

Proposed semi-annual reconstitution with a published rule log. Additions, deletions, mergers and delistings would be recorded with dates and source filings.

5. Benchmark

A broad equity benchmark (for example a total-market or large-cap index) would be named only after its data licence permits comparison and display. Until then, no comparison is shown.

6. Dividends and currency

Any future calculation would state whether it is price-only or total return (dividends reinvested), and how non-U.S. listings are converted to one currency. Mixing the two silently overstates or understates results.

7. Survivorship bias

Choosing today's survivors and measuring their past flatters results, because companies that were acquired, delisted or went bankrupt drop out. Any back-history would have to use point-in-time constituents. That is one reason none is published here. Distressed or delisted laboratory companies would stay in the record. See Laboratories Under Pressure.

8. Data licensing

Displaying prices, returns or index levels publicly requires a market-data licence that includes redistribution rights. Laboratory Sector Today has no such licence today, so the Laboratory Markets ticker shows company, symbol and exchange only.

9. Independence and conflicts

Editorial staff do not accept payment from listed companies to be included in, or excluded from, this watchlist. Any staff holdings in candidate companies will be disclosed on this page before constituents are published. No such disclosures have been filed yet, because no constituents exist.

Verified example listings (not selections)

Listings verified against each company's investor-relations site (see each profile for the source link).